Evidence map›Paper›PMID 31044281›Full record

ReviewCurrent infectious disease reports2019

Impact of Socio-Economic Factors on Increased Risk and Progression of Rheumatic Heart Disease in Developing Nations.

Neha Sharma, Devinder Toor

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current infectious disease reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Global heart · 2026
    Review
  5. Review
  6. Rheumatic heart disease burden and determinants in cardiac patients: A follow up care concern in Ethiopia.International journal of cardiology. Cardiovascular risk and prevention · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Raising awareness for rheumatic mitral valve disease.Global cardiology science & practice · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Neha SharmaAmity Institute of Virology and Immunology, Amity University, Sector-125, Noida, Uttar Pradesh, 201313, India.
Devinder ToorAmity Institute of Virology and Immunology, Amity University, Sector-125, Noida, Uttar Pradesh, 201313, India. dtoor@amity.edu.
Amity University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewRheumatic heart disease (RHD) is a global health concern especially in low-income settings. Morbidity and mortality data from the World Health Organization (WHO) and global burden studies emphasizes on the prioritization of RHD on a global platform. Genetic, environmental, and socio-economic factors determine the sustainability and progression of RHD in various populations. In developing countries, low socioeconomic status (SES) is a vast and inevitable challenge in combating RHD. Concurrence between low SES and RHD has been well documented by several studies, but there is a paucity of data to understand comprehensive interdependency of low SES and RHD. In this review, we have made an attempt to present the overall correlation between SES and increased risk of RHD by examining and highlighting the role of key components of SES in different populations throughout the world as reported in literature. RECENT

findingsIn the recent past, developed countries have reported success stories regarding amelioration of RHD due to improved living conditions and better access to healthcare. Whereas, in low-income settings, various socio-economic parameters such as overcrowding, illiteracy, low monthly income, maternal employment, rural dwelling, and less access to good quality healthcare are the core challenges which significantly impose an increased risk of RHD. Overall, there is significant evidence which confirms the role of SES in increased risk and progression of RHD, but vigorous and systematic studies need to be done to evaluate the cumulative effect of SES. Also, it will be helpful in dissemination of efficient primary and secondary prevention of RHD. Additionally, another aspect of this review was to assess the plausible impact of low SES on the clinical spectrum of RHD which might characterize SES as an authoritative marker for disease progression and severity.

Indexed as

Developing nationsPopulation screeningRheumatic heart diseaseSocioeconomic factors

Identifiers

PMID31044281
OpenAlexW2943579658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.